Core Laboratories Inc expected to post earnings of 9 cents a share - Earnings Preview
Core Laboratories Inc expected to post earnings of 9 cents a share - Earnings Preview
Core Laboratories Inc CLB.N, CLB is expected to show a fall in quarterly revenue when it reports results on July 29 for the period ending June 30 2026
The Houston Texas-based company is expected to report a 3.9% decrease in revenue to $125.1 million from $130.16 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.The company's guidance on April 29 2026, for the period ended June 30, was for revenue between $123.00 million and $131.00 million.
LSEG's mean analyst estimate for Core Laboratories Inc is for earnings of 9 cents per share. The company's EPS guidance on April 30 2026, for the period ended June 30, was between $0.06 and $0.12
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Core Laboratories Inc is $13.50, about 15.7% above its last closing price of $11.67
The company's guidance on April 29 2026 for the period ended June 30 was for Earnings before Interest and Taxes between USD6.4 million and USD10.2 million.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 0.09 | 0.11 | 0.06 | Missed | -44.6 |
Dec. 31 2026 | 0.20 | 0.19 | 0.21 | Beat | 11.3 |
Sep. 30 2025 | 0.19 | 0.19 | 0.22 | Beat | 14 |
Jun. 30 2025 | 0.18 | 0.19 | 0.19 | Met | 0.7 |
Mar. 31 2025 | 0.15 | 0.15 | 0.14 | Missed | -3.7 |
Dec. 31 2024 | 0.22 | 0.22 | 0.22 | Met | 0.7 |
Sep. 30 2024 | 0.23 | 0.23 | 0.25 | Beat | 8.2 |
Jun. 30 2024 | 0.21 | 0.21 | 0.22 | Beat | 6.6 |
This summary was machine generated July 27 at 20:03 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Core Laboratories
See all newsCore Laboratories Inc reports results for the quarter ended June 30 - Earnings Summary
Core Laboratories Q2 revenue falls as geopolitical disruptions weigh
Brief: Core Laboratories Q2 EPS USD 0.13
Core Laboratories Inc expected to post earnings of 9 cents a share - Earnings Preview
Core Laboratories Q1 profit halves as Middle East disruptions, weather weigh